Harvard Business Review

MARCH 13, 2012

And of course that's true — but the commodities market has been booming only in recent years, and the bank's track record is long and impressive. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa?

Biotechnology 9

Biotechnology Real Estate Tourism Banking 9

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. Of course, anyone can write down words, call them values, and incur no change. To save the 20-year-old company, I had to get it operating like a start-up. I believe that these rules

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

OCTOBER 1, 2014

While of course healthy economies include adequate numbers of start-ups (as well as big companies, family businesses, and micro-enterprises), we believe that entrepreneurial scale-ups deserve more attention than they’re currently getting.

Entrepreneur 11

Entrepreneur Biotechnology Real Estate Innovation 11

Harvard Business Review

MARCH 28, 2012

Of course, innovation is to some extent always a gamble. In pharma, Johnson & Johnson's 1999 acquisition of Centocor brought in blockbuster biotechnology innovations led by rheumatoid arthritis drug Remicade. Just 13 months after buying Palm for $1.2

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

MARCH 2, 2012

HBS welcomes 6,360 foreign nationals (64% of the total) to its executive education courses each year, enriching the experiences for Americans as well. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

DECEMBER 30, 2011

That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. I remember sitting there and saying, 'There's got to be a another way.'". Developing people is a process — not an event.

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

FEBRUARY 22, 2013

Years of development, energy, and, of course, money have gone into it. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. Your company has just developed an amazing new product. Hype and excitement behind the launch pushes it into high gear. What do you do next?

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

AUGUST 17, 2015

On the front page of a Cuban newspaper recently there was an item about a two-story home in the old city of Havana that crumbled—and that in the course of its collapse, killed four people. It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

MAY 10, 2016

In the course of research for our book , we’ve found that this approach also provides an ideal methodology for leaders to identify which M&A deals are most likely to pay off — a disciplined approach that acts as a kind of lens for effectively distinguishing gold from iron pyrite in assessing potential company synergies.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Consider another scenario focused on compelling patients to stay the course with treatment. They’re also sharing risk. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Tanveer Naseer

OCTOBER 20, 2015

The first leader was someone I worked with as part of the management team at a biotechnology firm, and how he guided our organization during the merger of our North American parent company with a much larger European multinational.

Power 100

Power Long-term Uncertainty Biotechnology 100

Harvard Business Review

FEBRUARY 19, 2015

” It’s a question only you can answer, of course. ” Kate left her job at PerkinElmer in February 2014; the next month, she and her business partner started ORIGƷN, a Boston-based biotechnology company. “Following your passion might seem daunting,” says Clark. ” Principles to Remember. .

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

FEBRUARY 3, 2015

Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. But of course, that depends a lot on what a person’s job is. Teach a course at a university or local college. Spend a day with a millennial in your company.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

AUGUST 4, 2016

Women, of course, are not the only group to experience stereotype threat. In one study, female and male MBA students were paired and asked to negotiate the purported purchase of a biotechnology plant. (Women who are not primed to think about gender gaps in math perform just as well as men do.)

Stress 8

Stress Biotechnology Self-aware Resources 8

Harvard Business Review

JULY 22, 2015

” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. Of course it was natural for a boss to have mixed feelings about seeing a valued employee move on, but David was more than Mark’s manager: He was his mentor. ” Mark said.

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

MARCH 17, 2014

In impact investing, we need to find a way to place that same premium on social impact by valuing the public good being created – just like we do in early stage R&D in science, IT, health, and biotechnology. We allowed microfinance and the venture capital industry the time and space to develop over a few decades.

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. ” Of course, once the collective breakthroughs become exciting new products, IBM and other members, like Intel and Microsoft, fight like dogs. vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

MARCH 30, 2017

Of course, there is a ways to go, but progress has been made. We worked with a startup biotechnology company. Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. It cannot be predicted or easily orchestrated.

Diversity 8

Diversity Team Biotechnology Execution 8